Herbas VPB

Print
EN | LT
LT - Wnt signalinio kelio indazoliniai slopikliai ir jų terapinis panaudojimas
EN - INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 471/04 (2006.01)
A61K 31/437 (2006.01)
A61K 31/4545 (2006.01)
A61K 31/444 (2006.01)
A61K 31/496 (2006.01)
A61K 31/5377 (2006.01)
A61P 35/00 (2006.01)
A61P 31/10 (2006.01)
A61P 31/12 (2006.01)
A61P 19/00 (2006.01)
A61P 25/28 (2006.01)
European patent
(11) Number of the document 2760285
(13) Kind of document T
(96) European patent application number 13772420.9
Date of filing the European patent application 2013-03-13
(97) Date of publication of the European application 2014-08-06
(45) Date of publication and mention of the grant of the patent 2017-06-21
(46) Date of publication of the claims translation 2017-10-10
PCT application
(86) Number PCT/US2013/031055
Date 2013-03-13
PCT application publication
(87) Number WO 2013/151708
Date 2013-10-10
Priority applications
(30) Number Date Country code
201261620107 P 2012-04-04 US
Inventors
(72)
HOOD, John, US
WALLACE, David, Mark, US
KC, Sunil, Kumar, US
Grantee
(73) BioSplice Therapeutics, Inc., 9360 Towne Centre Drive, San Diego, CA 92121, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Wnt signalinio kelio indazoliniai slopikliai ir jų terapinis panaudojimas
  INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF
Last renewal fee
Payment date Validity (years) Amount
2025-03-05 13 289.00 EUR
Next renewal fee
2026-03-13